Why Capricor Therapeutics, Inc. (CAPR) stock rose 26.5% on Wednesday, November 11, 2026
Capricor Therapeutics, Inc. (CAPR) closed at $11.22, up 26.49% on Wednesday, November 11, 2026, on volume of 9,932,382 shares (1.6× its 3-month average); market value about $700.0M, according to Nexqual market data (nexqual.com/moves/2026-11-11/CAPR).
What happened: primary sources
Events Nexqual found for CAPR on Wednesday, November 11, 2026 or the trading day before (November 10, 2026), each linked to its primary source:
- Nov 10, 2026: Reported quarterly results (SEC 8-K) for the quarter ended Sep 30, 2026: EPS −$0.73 vs consensus −$0.41 (miss), on the analysts' basis (usually adjusted, not GAAP). source
- Nov 10, 2026: SEC 10-Q: Quarterly report, period ended Sep 30, 2026 source
- Nov 11, 2026: Jones Trading: Upgrade, Hold → Buy, price target $25
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on CAPR
CAPR stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 11, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt